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Summary 
The role of epicardial adipose tissue (EAT) volume in subclinical left atrial (LA) dysfunction is 
unclear. Therefore, we aims to evaluate the relationships between EAT volumes, and LA functions 
and global longitudinal strain assessed in people without obstructive coronary artery disease or 
atrial fibrillation. We found that BSA-indexed total EAT was closely associated with impaired 2D 
LA global longitudinal strain, reduced 3D LA ejection fraction and reduced 3D active LA ejection 
fraction. 
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Abstract 
Background: Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot. Although 
EAT volume is associated with the incidence and burden of atrial fibrillation (AF), its role in 
subclinical left atrial (LA) dysfunction is unclear. The present study aims to evaluate the 
relationships between EAT volumes, LA function and LA global longitudinal strain. 
Methods: One hundred and thirty people without obstructive coronary artery disease (CAD) or AF 
were prospectively recruited into the study in Australia and underwent cardiac computed 
tomography (CT) and echocardiography. EAT volume was quantified from cardiac CT. 
Echocardiographic 3-dimensional (3D) volumetric measurements and 2-dimensional (2D) 
speckle-tracking analysis were performed.  
Results: Using the overall median BSA-indexed total EAT volume (EATi), the study cohort was 
divided into two groups of larger and smaller EATi volume. Subjects with larger EATi volume had 
significantly impaired LA reservoir function (3D LA ejection fraction, 46.1% ± 8.9% vs. 49.0% ± 
7.0%, P=0.044) and reduced LA global longitudinal strain (37.6% ± 10.2% vs. 44.1% ± 10.7%, 
P<0.001). Total EATi volume was a predictor of impaired 2D LA global longitudinal strain 
(standardized β = -0.204, P=0.034), reduced 3D LA ejection fraction (standardized β = -0.208, 
P=0.036) and reduced 3D active LA ejection fraction (standardized β = -0.211, P=0.017). Total 
EATi volume, rather than LA EATi volume, was the more important predictor of LA dysfunction. 
Conclusions: Indexed EAT volume is independently associated with subclinical LA dysfunction 
and impaired global longitudinal strain in people without obstructive coronary artery disease or a 
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history of AF. 
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Introduction 
Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot between the 
myocardium and visceral pericardium. As EAT is in direct contact with the adjacent myocardium, 
there are potential physiological (including paracrine) interactions between these two tissues.1 
With its proatherosclerotic effects and tendency to secrete proinflammatory mediators, EAT is 
associated with the pathogenesis of coronary artery disease (CAD) and the metabolic syndrome.2 
The volume of EAT is a predictor for persistence of arrhythmia.3 Additionally, EAT volumes could 
predict atrial fibrillation (AF) recurrence after catheter ablation.4 This interplay between EAT and 
AF may involve adipocyte infiltration and atrial fibrosis, resulting in functional remodeling of the 
atria and arrhythmogenesis. 
During the cardiac cycle, the LA serves multiple functions, acting as a reservoir for 
pulmonary venous return during left ventricular (LV) systole, a conduit for blood flow during 
early diastole, and an active pump chamber that augments ventricular filling in late diastole.5 LA 
functional remodeling is commonly marked by decreased LA function, which can be assessed by 
2D and 3D echocardiography.6, 7 LA 2D longitudinal strain has been reported to correlate strongly 
with the extent of LA fibrosis and remodeling, while 3D echocardiography offers better evaluation 
of LA deformation.8 In the present study, we aimed to evaluate the association between EAT 
measured by cardiac CT and LA function assessed by 2D and 3D echocardiography in people 
without obstructive CAD or atrial fibrillation. 
 
Methods 
Study population 
Study participants were prospectively recruited from a single Australian tertiary hospital and 
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those in low to intermediate risk chest pain underwent a cardiac CT examination, with inclusion 
criteria of sinus rhythm at the time of enrollment. Exclusion criteria included clinical heart failure 
(NYHA class II or higher or higher symptoms within six months before screening), moderate or 
severe valvular disease, obstructive coronary artery disease (defined as >50% stenosis on cardiac 
CT) or previous history of myocardial infarction, pulmonary hypertension, congenital heart 
disease, cardiac surgery, history of AF and contraindications to cardiac CT examination.  
All patients gave written informed consent to the procedure. The study was approved by the 
ethics committee of the participating institution. 
Cardiac CT and EAT quantification 
A total of 130 subjects underwent cardiac CT examination (including calcium scoring and CT 
coronary angiography) with an electrocardiograph-gated, dual-source CT system (Somatom 
Definition Flash, Siemens Healthcare, Forchheim, Germany). The imaging parameters were as 
follows: slice collimation 2×128×0.6mm; gantry rotation time 280ms; tube voltage 100 or 120 kV 
according to participant’s body mass index; and effective tube current 80mA/s. A bolus of 75 mL 
ioversol (Optiray 350; Mallinckrodt Medical, St Louis, MO) was injected and image acquisition 
was initiated at 60% of the RR interval. Before the scan, β-blockers (25–100 mg metoprolol orally) 
were administrated and participants were instructed to hold their breath during the acquisition of 
images. 
All images were processed with an offline with a workstation (SyngoVia, Siemens Healthcare; 
MASS V2010-EXP, Leiden University Medical Center, Leiden, The Netherlands). Serial 
cross-sectional images were generated from raw data to reformat the images to a slice thickness of 
0.75 mm. In order to quantify EAT volume, the pericardium was manually traced from the 
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pulmonary artery bifurcation to the diaphragm on each cross-sectional image. Within this region, a 
CT attenuation threshold between –50 and –200 Hounsfield Units was defined as EAT.9-11 The 
EAT surrounding the LA (LA EAT) was quantified by manually tracing from the pulmonary artery 
to the coronary sinus at atrial end-diastole. In each participant, quantification of the total EAT and 
LA EAT was verified by two investigators. 
Echocardiography 
All study subjects underwent a transthoracic echocardiographic examination at rest in the left 
lateral decubitus position with a Vivid E9 ultrasound system (GE, Vingmed, Horten, Norway) 
before or after undergoing cardiac CT within a median time of one month (25th and 75th 
percentage, 0.4 and 1.7 months). Images and measurements were acquired according to the 
recommendations of the American Society of Echocardiography. Left ventricular ejection fraction 
(LVEF), LV mass index, LV end-diastolic volume index (LVEDVi), and LV end-systolic volume 
index (LVESVi) were calculated from 3D data sets and indexed to body surface area (BSA). 
Images were obtained during breath-hold and the mean 3D frame rate was 34.6 frames per second.  
LA size and function assessment 
A 3D pyramidal full volume of the LA was obtained from the apical view with 
breath-holdover four consecutive cardiac cycles.12 Sector dimensions, depth, and image contrast 
were optimized to include the whole LV and LA. The calculation of LA volumes was performed 
using the 3D LV volume application in Echopac based on a semi-automated contour-tracing 
algorithm. LA volumes were indexed for BSA. Maximal LA volume (MaxLAVi) was measured at 
the end of LV systole just before mitral valve opening. Pre-atrial contraction volume (PaLAVi) 
was calculated just before atrial contraction. Minimal atrial volume (MinLAVi) was obtained at 
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the closure of the mitral valve in end diastole. 
LA reservoir function could be described with LAEF [LAEF=(MaxLAVi－MinLAVi)/ 
MaxLAVi×100] and LA expansion index [LAEI=(MaxLAVi－MinLAVi)/ MinLAVi×100]. LA 
conduit function was defined as passive LAEF [p-LAEF=(MaxLAVi－PaLAVi)/ MaxLAVi×100]. 
LA pump function was measured as active LAEF [(PaLAVi－MinLAVi)/PaLAVi×100].6 
2D speckle-tracking echocardiography 
All 130 subjects were eligible for speckle-tracking echocardiographic analysis. Longitudinal 
LA strain was performed offline using dedicated software (EchoPac version 113, GE, Vingmed). 
Briefly, a line was manually drawn along the LA endocardium at LA minimum volume and the 
region of interest would be generated to cover the full thickness of the LA wall. The software 
automatically tracked the contour on subsequent frames and tracking was manually approved. For 
each 4-, 2- and 3-chamber views, the LA cavity was divided into six segments (the basal, mid and 
apical parts of two opposing walls) and strain curves were generated for each segment. With the 
reference of point set at the onset of the R-wave of electrocardiography, global LA longitudinal 
strain was calculated as average of values evaluated from the 4-, 2- and 3-chamber images and 
expressed as positive value.13, 14 Echocardiography analysis, including 3D LA volumes, LA 
function and speckle tracking, were all undertaken by investigators unaware of the results of CT 
EAT volume. 
Statistics 
All continuous variables were tested for normal distribution using the Kolmogorov-Smirnov 
test and presented as mean ± 1 SD if normally distributed. Categorical variables were presented as 
frequencies and percentages. The unpaired Student t test was used in normally distributed 
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continuous variables, and a Chi-square test or Fisher exact test was adopted to compare 
categorical variables as appropriate. Relations between continuous variables were assessed using a 
simple regression analysis. Additionally, multivariate linear regression analyses, with 
backward-elimination approach, were run to identify the variables with the strongest association 
with LA function parameters. The variables with P<0.1 from univariable analysis were selected 
for the multivariable analysis. In 10 randomly selected subjects, the intra- and interobserver 
variability for LA volumes and speckle-tracking parameters were assessed. All analyses were 
performed with IBM SPSS Statistics 24.0 (IBM Corp, Armonk, NY), and a 2-tailed P<0.05 was 
considered statistically significant. 
 
Results 
Baseline characteristics 
Demographic characteristics are presented in Supplemental Table S1. Of the 130 study 
subjects, 53.1% were male, and the mean age was 53 ± 9 years. Based on the overall median BSA 
indexed total EAT volume (EATi) of 48.4 cm3/m2, the study cohort was divided into two groups 
with larger and smaller EATi volume. Compared with the smaller EATi group, the larger EATi 
group had significantly higher mean waist/hip ratio (0.95 ± 0.07 vs. 0.92 ± 0.08, P=0.013). Mean 
blood pressure was also higher in the larger EATi group: systolic blood pressure 137 ± 17 vs. 130 
± 14 mmHg, P=0.009; diastolic blood pressure 83 ± 12 vs. 79 ± 8 mmHg, P=0.029. Although the 
high density lipoprotein (HDL) level was lower in the larger EATi group (1.2 ± 0.3 vs. 1.3 ± 0.4 
mmol/L, P=0.03), there were no significant differences in the levels of total cholesterol, low 
density lipoprotein or triglycerides. 
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Cardiac CT and echocardiography characteristics 
As shown in Table 1, there is a trend to have more non-obstructive coronary atherosclerosis 
in the larger EATi group (64.6% vs. 49.2%, P=0.077), but Agatston calcium score was not 
different between the two groups (P=0.38). Regarding the ventricular echocardiographic 
parameters, there was no significant difference in LV mass index, LVESVi or LVEF. In diastolic 
function assessment, E/A ratio (1.02 ± 0.36 vs. 1.17 ± 0.31, P=0.012) and average of tissue 
Doppler mitral annular velocities (E’ average) (8.4 ± 2.1 vs. 9.6 ± 2.1 cm/s, P=0.001) were lower 
in the larger EATi group while E-wave deceleration time was longer (207 ± 43 vs. 185 ± 38 ms, 
P=0.003).  
On 3D echocardiographic volumetric analysis, the larger EATi group had relatively reduced 
reservoir function (LAEF, 46.1 ± 8.9 vs. 49.0 ± 7.0 %, P = 0.044). LA conduit and pump function 
were not statistically different between the groups, although there was a trend to lower LAEF in 
the larger EATi group (27.1 ± 8.4 vs. 29.6 ± 7.5 %, P=0.079). LA global longitudinal strain was 
reduced significantly in larger EATi group (37.6 ± 10.2 vs. 44.1 ± 10.7 %, P<0.001) (Figure 1). 
There was no significant difference with respect to MaxLAVi, PaLAVi or MinLAVi between the 
two groups. 
Age and gender were not associated with EATi volume and LA function (Supplemental Table 
S2). 
Determinants of LA volume and function  
Table 2 shows univariate and multivariate linear regression analyses for determinants of LA 
global longitudinal strain. When all significant univariate determinants (P<0.1) were entered into 
the multivariate model, only total EATi volume (standardized β = -0.204, P=0.034), eGFR 
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(standardized β = 0.287, P=0.003) and E’ average (standardized β = 0.416, P<0.001) were 
independent determinant of LA global longitudinal strain. Figure 1 shows the correlation between 
total EATi volume and LA global longitudinal strain. Similarly, in regards to markers of LA 
volumetric remodeling, total EATi volume demonstrated negative correlations with LAEF 
(standardized β = -0.208, P=0.036) and active LAEF (standardized β = -0.211, P=0.017) (Table 3 
and Table 4). The LA conduit function, assessed by 3D passive LAEF, was less significantly 
associated with total EATi volume (Table 5). Similar to total EATi volume, the absolute EAT 
volume also correlated with LA global longitudinal strain (standardized β = -0.241, P =0.013), 
LAEF (standardized β = -0.184, P= 0.06) and active LAEF (standardized β = -0.206, P= 0.02). 
Compared with total EATi volume, LA EATi volume had weaker associations with LA global 
longitudinal strain (r=-0.235, P=0.007) and LAEF (r=-0.229, P=0.01). Additionally, if both total 
EATi and LA EATi volumes were both forced into multivariate regression analyses, only total 
EATi volume would remain as a significant determinant of LA function. However, the correlation 
between total and LA EAT was strong (r=0.805, P<0.001). 
Similar associations were demonstrated when the entire analysis was repeated using EAT 
values not indexed for BSA. 
Reproducibility 
The intra- and interobserver correlations for LA global longitudinal strain were 0.99 and 0.97, 
for MinLAVi were 0.98 and 0.95, for MaxLAVi were 0.98 and 0.82 and for PaLAVi were 0.98 and 
0.84 respectively. Reproducibility values for EAT volumes were published previously.11 
 
Discussion 
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This study evaluated the relationships between total and LA EAT volume and LA function in 
subjects without obstructive CAD. We found that total EATi volume was inversely associated with 
impaired LA longitudinal strain, LAEF and active LAEF, independent of potential confounders. 
The association between EAT volume and impaired LA function  
2D speckle tracking strain imaging is an evolving technique for the evaluation of myocardial 
deformation and has been used widely for the assessment of LA function.15 Compared with 
volumetric measurements, LA myocardial analysis using 2D speckle tracking echocardiography 
may detect an early alteration of LA function.13, 16 It has been shown that global peak atrial 
longitudinal strain is a strong and independent predictor of LA fibrosis.17 Additionally, LA strain, 
evaluated by cardiac magnetic resonance image, was shown a strong degree correlation with 
fibrofatty replacement at a histological level. 18 In our present study, larger EATi volume was 
closely associated with more impaired LA global longitudinal strain, regardless of confounding 
factors. EATi volume negatively correlated with 3D-LAEF and 3D-active LAEF. Gianluca et al. 
showed that increased EAT thickness was significantly correlated with atrial enlargement and 
impairment in diastolic filling in morbidly obese subjects,19 while our work provides further 
insight into the pathophysiological role of EAT by demonstrating its adverse relationship with LA 
function in the early stage of LA remodeling. 
Compared with total EATi volume, the LA EATi volume correlated less strongly with LA 
function. This finding provides support for the theory that the adverse effects of EAT on 
myocardial function may be due mainly to paracrine effects on myocardial structure and 
contractility instead of physical constriction.20, 21However, given the correlation between LA EAT 
and total EAT, statistical variations in sampling could influence the results.  
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Pathophysiological role of EAT on LA 
According to the classical view on arrhythmia generation, the occurrence and persistence of 
AF results from the interaction between a trigger, a substrate and activation of the autonomic 
nervous system.22 Within this model, EAT may play a role as a possible substrate (causing various 
alterations of the structural and functional properties of the atrial myocardium) or trigger 
(influencing sympathetic tone). For instance, EAT could reduce the secretion of anti-inflammatory 
and anti-atherogenic adiponectins and express large amounts of inflammatory cytokines and 
chemokines, contributing to increased expression of cardiovascular risk factors.23-25 Several 
EAT-expressed adipokines are involved in the pathogenesis of AF, many of which participate in 
structural remodeling of the atrial myocardium. For example, Activin A produced by EAT could 
induce the expression of TGF–β1 and –β2 in the atria, contributing to fibrosis of the atrial 
myocardium.21 Additionally, fatty infiltration of the myocardium is another potential mechanism 
underlying the relationship between EAT and AF.22, 26 Loss of myocardial continuity would lead to 
the formation of local arrhythmogenic substrate. It has been reported that EAT contains abundant 
stem cells.27, 28 These stem cells could potentially differentiate into myofibroblasts, produce 
abundant extracellular matrix and take part in the pathological mechanisms of atrial remodeling. 
EAT and atrial fibrillation 
EAT is likely to play a pathophysiological role in the development of AF.29 The association 
between EAT and AF has been described in many experimental and clinical studies.30-32 
Thanassoulis and coworkers conducted analysis based on the Framingham Heart Study Offspring 
and Third Generation Cohorts and demonstrated the association between pericardial fat (adipose 
fat within the pericardial sac) and AF independent of other measures, even after adjustment for 
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established AF risk factors.33 Gaeta et al. performed a meta-analysis of observational case series 
studies.34 After summarizing seven studies,35-41 a statistically significant difference in EAT volume 
was observed between healthy subjects and those with AF (95% confidence interval [CI] = 21.5, 
42.5). Moreover, the presence of other cardiovascular risk factors (age, hypertension and diabetes) 
did not weaken the AF-EAT relationship. This relationship was much stronger in patients with 
persistent AF who showed an increased amount of EAT with respect to patients with paroxysmal 
AF (EAT difference 29.6 ml, 95% CI =12.7, 46.5). Furthermore, EAT was independently 
associated with post-ablation recurrence of AF.37 
Study limitations 
There are several limitations to the present work. Firstly, associations between larger EAT 
volume and impaired LA function do not prove that the increased EAT will necessarily lead to 
worsening LA impairment and increased incidence of AF over time. Therefore, animal modeling 
and long-term follow-up human studies are necessary to demonstrate the clinical significance of 
EAT. Secondly, the 3D LA volumes were measured using the LV application in EchoPac and this 
might affect accuracy. Thirdly, the pathophysiological mechanisms of our demonstrated 
associations remain unclear. Mechanistic investigations elucidating pathophysiology and histology 
are needed. 
Conclusions 
EAT volume is independently associated with impaired LA function as assessed by 2D and 
3D echocardiography in our study cohort without obstructive coronary artery disease or atrial 
fibrillation. Further studies would help to improve the understanding of this relationship between 
EAT and LA function. 
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Figure legends 
Figure1. Correlation between total epicardial adipose tissue volume index and left atrial global 
longitudinal strain. 
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Table 1.Cardiac tomography and echocardiography with groups separated by medium EATi. 
Characteristics Total 
 
(n=130) 
Larger EATi 
group 
(n=65) 
Smaller EATi 
group 
(n=65) 
P value 
Cardiac tomography     
Total EATi volume 49.7 ± 20.7 66.5 ± 14.2 32.8 ± 9.5 <0.001 
LA EATi volume 13.5 ± 6.5 17.8 ± 5.5 9.2 ± 4.0 <0.001 
Presence of non-obstructive coronary 
atherosclerosis, n (%) 
74 (56.9) 42 (64.6) 32 (49.2) 0.077 
Agatston calcium score 46.1 ± 121.0 36.6 ± 96.8 55.5 ± 141.3 0.376 
Echocardiography     
LV mass index, g/m2 72.4 ± 9.3 71.4 ± 8.4 73.4 ± 10.0 0.226 
LVEDVI, mL/m2 57.2 ± 10.6 55.2 ± 10.2 59.2 ± 10.7 0.035 
LVESVI, mL/m2 23.2 ± 5.1 22.7 ± 4.6 23.6 ± 5.5 0.300 
LVEF, % 59.5 ± 4.7 58.8 ± 4.4 60.2 ± 4.9 0.095 
E/A ratio 1.09 ± 0.34 1.02 ± 0.36 1.17 ± 0.31 0.012 
S/D ratio 1.29 ± 0.38 1.31 ± 0.44 1.26 ± 0.30 0.461 
E-wave deceleration time, ms 196 ± 42 207 ± 43 185 ± 38 0.003 
E’ average, cm/s 9.0 ± 2.2 8.4 ± 2.1 9.6 ± 2.1 0.001 
E/E’ ratio 8.9 ± 2.5 8.8 ± 2.5 9.0 ± 2.6 0.758 
LA volume     
3D-Maximum LA volume index, mL/m2 25.8 ± 6.7 24.6 ± 7.4 26.9 ± 5.8 0.056 
3D-precontraction LA volume index, mL/m2 18.4 ± 4.9 17.9 ± 5.5 18.9 ± 4.3 0.242 
3D-Minimum LA volume index, mL/m2 13.4 ± 3.6 13.1 ± 3.9 13.7 ± 3.2 0.370 
LA reservoir function     
3D-LA emptying fraction, % 47.5 ± 8.1 46.1 ± 8.9 49.0 ± 7.0 0.044 
3D-LA expansion index, % 95.3 ± 31.4 90.8 ± 33.8 99.7 ± 28.5 0.110 
LA conduit function     
3D-Passive LA emptying fraction, % 28.4 ± 8.0 27.1 ± 8.4 29.6 ± 7.5 0.079 
LA pump function     
3D-Active LA emptying fraction, % 26.6 ± 9.1 25.9 ± 10.0 27.3 ± 8.3 0.386 
2D-Global atrial longitudinal strain, % 40.9 ± 10.9 37.6 ± 10.2 44.1 ± 10.7 <0.001 
3D: 3-dimensional; A: peak A mitral velocity; E: peak E mitral velocity; EATi: indexed total EAT volume;  
E/A ratio: peak early diastolic mitral flow velocity to peak mitral flow velocity at atrial contraction; LA: left 
atrial; LV: left ventricular; LVEDVI: LV end-diastolic volume index; LVESVI: LV end-systolic volume index; 
E’ average: average of tissue Doppler mitral annular velocities; S/D ratio: the pulmonary venous peak systolic 
(S) to diastolic (D) flow velocities. 
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Table 2. Univariable and multivariable linear regression models for LA strain. 
 Univariable Multivariable 
 Standardized β P value Standardized β P value 
Total EATi volume -0.336 <0.001 -0.204 0.034 
Body mass index -0.254 0.003 -0.050 0.602 
Systolic blood pressure -0.229 0.009 -0.115 0.228 
Age -0.201 0.022 0.015 0.897 
Hyperlipidemia -0.176 0.045 0.001 0.992 
Waist/hip -0.151 0.091 0.087 0.364 
Hypertension -0.146 0.098 -0.047 0.615 
Non-obstructive coronary 
atherosclerosis 
-0.167 0.058 0.174 0.095 
eGFR 0.363 <0.001 0.287 0.003 
HDL 0.234 0.022 0.084 0.380 
E’ average 0.391 <0.001 0.416 <0.001 
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Table 3. Univariable and multivariable linear regression models for LAEF. 
 Univariable Multivariable 
 Standardized β P value Standardized β P value 
Total EATi volume -0.254 0.004 -0.208 0.036 
Non-obstructive coronary 
atherosclerosis 
-0.179 0.044 -0.079 0.454 
Age -0.273 0.002 -0.292 0.004 
Hyperlipidemia -0.212 0.017 -0.106 0.301 
LVEDVI 0.206 0.020 -0.076 0.478 
eGFR 0.158 0.083 0.046 0.643 
LDL 0.188 0.070 0.128 0.196 
E’ average 0.187 0.035 -0.077 0.540 
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Table 4. Univariable and multivariable linear regression models for active LAEF.  
 Univariable Multivariable 
 Standardized β P value Standardized β P value 
E-wave deceleration time 0.198 0.026 0.238 0.008 
Total EATi volume -0.166 0.062 -0.211 0.017 
E/A ratio -0.157 0.079 -0.123 0.205 
Hyperlipidemia -0.171 0.054 -0.131 0.136 
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Table 5. Univariable and multivariable linear regression models for passive LAEF. 
 Univariable Multivariable 
 Standardized β P value Standardized β P value 
Non-obstructive coronary 
atherosclerosis 
-0.242 0.006 -0.239 0.017 
Age -0.322 ＜0.001 -0.260 0.010 
E/A ratio 0.240 0.007 0.054 0.605 
S/D ratio -0.216 0.015 -0.137 0.152 
LDL 0.195 0.061 0.171 0.078 
LVESVI 0.206 0.020 0.094 0.372 
LVEDVI 0.230 0.009 0.073 0.487 
E’ average 0.364 ＜0.001 0.162 0.196 
Total EATi volume -0.161 0.071 -0.033 0.744 
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